Neurology | Medical XPRT
Articles & Whitepapers
-
Protein Fusion Extends Drug Half-Life Technology
Protein fusion is a genetic recombination technique in which the DNA of an inactive peptide or protein chain segment to be grafted is recombined with the DNA of a drug and expressed together by engineered cells; no specialized grafting operations are required. In the current technology, the inactive peptide or protein chain segment used for protein fusion is the FC region of albumin and antibody. ...
-
Top 4 Things to Know About the Global Sleep Apnea Devices Market
The sleep apnea device market has undergone rapid transformation, driven by growing awareness about the consequences associated with disruptive or poor sleep conditions. Sleep apnea is a severe ...
News
-
ARAI-2PAM Barda Procurement Award
Broomfield, Colorado, 10/3/2022. Aktiv Pharma Group (Aktiv) today announced a procurement contract award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response ...
Aktiv Pharma Group Receives Grant Funding to Develop Tranexamic Acid Autoinjector
VisionQuest Abstract on Diabetic Peripheral Neuropathy Accepted by ADA
RTsafe’s core role for the development of German guidelines for a standard, safe and efficient implementation of Single-Isocentric Multi-Focal SRS throughout the country
Neeuro (Singapore) and epihunter (Belgium) partner to create new and innovative digital solutions for people with brain disorders
Equipment & Solutions
-
Showcase
Premium Multiplace Multiplace Hyperbaric Chamber
The OxyHelp OxyLife C Multiplace chamber is ideal for multiple users at the same time. This multiplace hyperbaric oxygen chamber allows either an assistant or an observer inside to monitor the user and assist with the session, electronic functions or emergencies. The different sizes of Multiplace HBOT chambers (2, 4 or 5-seater) can also fit cardio equipment like a stationary bike or can be ...
Upcoming Events
-
Showcase
12th Microbiome & Probiotics R&D and Business Collaboration Forum
Global Engage is pleased to announce the 12th Microbiome, Probiotics & Prebiotics R&D and Business Collaboration Forum, which is confirmed to be held on April 23-24 2024 in The Netherlands and co-located with the 6th Skin Microbiome & Cosmeceuticals Congress. This world-renowned event which attracted 265 industry, academic, and investment leaders last year, enables the discussion of ...